NanoViricides (NNVC) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free NNVC Stock Alerts $1.15 +0.01 (+0.88%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Initiates Coverage on NanoViricides (NYSE:NNVC)americanbankingnews.com - April 23 at 2:14 AMNanoViricides (NYSE:NNVC) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 15 at 2:18 AMNanoviricides Stock (AMEX:NNVC) Earnings Dates and Earning Callsbenzinga.com - February 26 at 10:47 AMNanoViricides boosts liquidity measures and manufacturing capacity to support clinical trialsproactiveinvestors.com - February 15 at 10:18 AMNanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizonfinance.yahoo.com - February 15 at 8:18 AMA New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?benzinga.com - February 1 at 10:26 AMClinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibioticsfinance.yahoo.com - February 1 at 9:15 AMNanoViricides successfully concludes first-in-human studyproactiveinvestors.com - January 29 at 11:27 AMNanoViricides makes progress as it completes dosing in Phase 1a COVID studyproactiveinvestors.com - January 29 at 9:27 AMSafety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Foundfinance.yahoo.com - January 29 at 9:27 AMNanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024benzinga.com - January 8 at 1:26 PMNanoviricides Inc NNVCmorningstar.com - January 7 at 1:52 PMNanoViricides, Inc.: NanoViricides to Present at the Biotech Showcase in San Fransiscofinanznachrichten.de - January 4 at 9:03 AMNanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387benzinga.com - December 1 at 12:59 AMNanoViricides completes Phase 1a/1b human clinical trial for its broad-spectrum antiviral drugproactiveinvestors.com - November 28 at 10:36 AMThe Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, Has Successfully Completed the First Part (Phase 1a), Reports NanoViricidesfinance.yahoo.com - November 28 at 9:05 AMNanoViricides continues to progress antiviral drug candidate...proactiveinvestors.com - November 15 at 10:27 AMNanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applicationsfinance.yahoo.com - November 15 at 7:52 AMNanoViricides updates investors on Phase 1a/1b trial of antiviral drug candidate for coronavirusproactiveinvestors.com - October 17 at 8:15 PMNanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Active Against Coronaviruses as well as RSVfinance.yahoo.com - October 16 at 8:52 AMNanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ETfinance.yahoo.com - October 12 at 8:06 AMNNVC: NanoViricides Begins Clinical Trial of NV-CoV-2finance.yahoo.com - September 5 at 2:46 PMNanoViricides progressing well with new Covid studyfinance.yahoo.com - August 31 at 8:19 AM$NNVC Reports Their Broad-Spectrum Antiviral Drugs Human Clinical Trial Is Progressing Successfullymsn.com - August 29 at 5:52 PMNanoViricides is leveraging its unique nanoviricide platform technology to create first-in-class drugs against virusesproactiveinvestors.com - August 23 at 2:15 PMThe Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricidesfinance.yahoo.com - August 21 at 6:59 AMSARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?benzinga.com - July 18 at 10:27 AMNanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analystfinance.yahoo.com - July 13 at 9:29 AMNanoViricides Shares Surge on NV-387 Showing in RSV >NNVCmarketwatch.com - July 11 at 1:36 PMWhy Are NanoViricides Shares Gaining Todaybenzinga.com - July 11 at 1:36 PMCompany’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricidesfinance.yahoo.com - July 11 at 8:36 AMNovel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?benzinga.com - July 10 at 12:33 PMNanoViricides says clinical trial progressing satisfactorily...NanoViricides says clinical trial progressing satisfactorily for...proactiveinvestors.com - July 8 at 6:11 PMClinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needsfinance.yahoo.com - July 6 at 8:32 AMNanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2finance.yahoo.com - June 29 at 3:51 PMNanoViricides commences clinical trials for its broad-spectrum antiviral drug NV-CoV-2proactiveinvestors.com - June 29 at 9:25 AMNanoViricides, Inc.: NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begunfinanznachrichten.de - June 29 at 7:09 AMNanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begunfinance.yahoo.com - June 29 at 7:04 AMNanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ETfinance.yahoo.com - May 31 at 8:00 AMBig box retailers lead mixed earnings week as consumers shift focus from goods to experiencesproactiveinvestors.com - May 19 at 6:46 PMNanoViricides ends fiscal 3Q with strong cash runway to begin clinical trials of broad-spectrum COVID drugproactiveinvestors.com - May 16 at 10:35 AMNanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Beginfinanznachrichten.de - May 16 at 8:20 AMNanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Beginfinance.yahoo.com - May 16 at 8:20 AMNanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York Cityfinance.yahoo.com - May 4 at 9:39 AMNanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredientfinance.yahoo.com - April 25 at 10:00 AMEF Hutton Reiterates NanoViricides (NNVC) Buy Recommendationmsn.com - April 19 at 9:51 AMNanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidatefinance.yahoo.com - April 17 at 10:09 AMNanoViricides using unique technology platform to fight against Virusesproactiveinvestors.com - April 12 at 5:31 PMNNVC: NanoViricides Technology Ready to Enter the Clinicfinance.yahoo.com - April 10 at 2:48 PMNanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidatesfinance.yahoo.com - April 4 at 9:42 AM Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 NNVC Media Mentions By Week NNVC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NNVC News Sentiment▼0.000.43▲Average Medical News Sentiment NNVC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NNVC Articles This Week▼10▲NNVC Articles Average Week Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Imunon News Kiora Pharmaceuticals News JanOne News Avalo Therapeutics News MIRA Pharmaceuticals News Edesa Biotech News Purple Biotech News Tonix Pharmaceuticals News Benitec Biopharma News Cocrystal Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NNVC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
